CD8A and squamous cell carcinoma: Further, kidney transplant recipients with a high proportion CD57+ of CD8 T cells have elevated risk of squamous cell carcinoma (66), and kidney recipients with an elevated proportion of CD57+ TEMRA have an elevated risk of late graft dysfunction (67).